Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DeCarvalho
    Junior Member
    • Jun 2012
    • 1

    #1

    Postdoctoral Fellow in Cancer Epigenomics at Ontario Cancer Institute - Toronto

    The Ontario Cancer Institute (OCI) at Princess Margaret Hospital - a teaching hospital of the University of Toronto - ranks in the top 5 cancer research centers in the world. Its research activities are concentrated on epigenomics, cancer immunotherapy, cancer stem cells, image-guided therapeutics, patient survivorship, and personalized medicine. The University of Toronto and its affiliated hospital research institutes comprise one of the largest and most productive centers of biomedical research in North America while the City of Toronto is ranked fourth in the Economist’s list of World’s Most Liveable Cities, and second in PriceWaterhouseCooper’s Cities of Opportunity in 2011.
    For more information about the institute: http://www.uhntrainees.ca/

    Computational Biology

    A bioinformatics Postdoctoral Fellow or Research Associate position is available immediately within the group of Daniel D. De Carvalho, Ph.D. Our lab focuses on understanding the mechanisms driving cancer-specific epigenetic alterations, with the ultimate goal of allowing target-specific epigenetic interventions. To achieve this goal, we perform functional genomic screening, combined with systems biology and a variety of genome-wide profiling of epigenetic modifications, using next-generation sequencing (NGS) and microarray technologies. We are specifically seeking individuals with strong computational, bioinformatics, and/or statistical backgrounds to be involved in NGS data analysis. Applicants must be highly motivated and able to communicate effectively in English.

    For more information about our work, prospective applicants are encouraged to refer to the following papers:
    Cancer Cell. 2012 May 25;21(5):655-67 (PMID: 22624715);
    Cell. 2011 Dec 9;147(6):1283-94 (PMID: 22153073);
    PNAS. 2011 Aug 30;108(35):14497-502 (PMID: 21844352);
    PLoS Genet. 2011 Feb 3;7(2):e1001286 (PMID: 21304883);
    Nat Biotechnol. 2010 Oct 13;28(10):1069- 1078 (PMID: 20944599);
    Oncogene. 2011 Jan 13;30(2):223-33 (PMID: 20838376).

    Please send your curriculum vitae and the contact information for 3 references to Daniel D. De Carvalho, Ph.D. ([email protected]).

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...